Literature DB >> 36169773

Perceived Risk of HIV Infection and Acceptability of PrEP among Men Who Have Sex with Men in Brazil.

Fabiane Soares1, Laio Magno2, Luís Augusto V da Silva3, Mark Drew Crosland Guimarães4, Andrea Fachel Leal5, Daniela Knauth6, Maria Amélia Veras7, Ana Maria de Brito8, Carl Kendall9,10, Ligia Regina Franco Sansigolo Kerr9, Inês Dourado11.   

Abstract

The HIV epidemic affects men who have sex with men (MSM) disproportionally in Brazil, and pre-exposure prophylaxis (PrEP) is effective for preventing HIV in this population. However, low perceived risk of HIV may influence the acceptability and decision to use PrEP. This study estimated the association between self-perception of HIV risk and acceptability of daily oral PrEP among Brazilian MSM. Respondent-driven sampling (RDS) was used for behavioral and biological surveillance to recruit 4,176 MSM 18 years or over in 12 Brazilian cities in 2016. Results were weighted using Gile's estimator in RDS Analyst software. Adjusted odds rations (OR) with 95% confidence intervals were calculated using multivariate logistic regression. Acceptability of daily oral PrEP was high (69.7%) among the 3,544 MSM available for analysis. Most participants self-reported low or moderate risk of HIV infection (67.2%) and a small proportion (9.3%) reported high risk. A dose-response relationship was observed between acceptability of PrEP and self-reported risk: PrEP acceptability was 1.88 times higher (OR 1.8; 95% CI: 1.24-2.85) among MSM whose perceived risk of HIV infection was low or moderate, and 5 times higher (OR 5.68; 95% CI: 2.54-12.73) among those who self-reported high risk compared to MSM reporting no HIV risk. MSM with the highest risk perception of HIV reported higher rates of PrEP acceptability. Given the availability of daily oral PrEP in the public health care system in Brazil, we suggest emphasizing counseling about self-perception of HIV risk as part of routine HIV prevention services.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Acceptability; Brazil; HIV infection; Men who have sex with men; PrEP; Sexual orientation

Year:  2022        PMID: 36169773      PMCID: PMC9517975          DOI: 10.1007/s10508-022-02342-3

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


Introduction

In Latin America, the HIV epidemic disproportionally affects men who have sex with men (MSM), who accounted for 40% of new HIV infections in 2018 (Unaids, 2019). In Brazil, in two nationwide surveys of MSM aged 18 and older conducted seven years apart, the prevalence of HIV among this age range was estimated to be 14.2% in 2009 and 18.4% in 2016 (Kerr et al., 2018; Kerr et al., 2013). Analyses of the data from these surveys show that MSM have little knowledge of HIV prevention, transmission, and treatment (Guimarães et al., 2019), or which sexual practices increase the risk of HIV, as well as low perceived risk of HIV (Guimarães et al., 2018). In this context, pre-exposure prophylaxis for HIV (PrEP) adds value to a set of combination prevention measures for MSM. Oral PrEP is available for daily use or as an event-driven antiretroviral for individuals who are HIV negative (World Health Organization, 2012, 2019). Its efficacy has been proven in different clinical trials (Baeten et al., 2012; Grant et al., 2010; J. M. Molina et al., 2017; Thigpen et al., 2012), and its effectiveness has been shown in demonstration studies (Cohen et al., 2015; Grinsztejn et al., 2018; Liu et al., 2016; Molina et al., 2019; Montgomery et al., 2016). In 2018, daily oral PrEP was included in the Brazilian national health system (Sistema Único de Saúde or SUS), for free, as part of the national public policy for HIV prevention targeting key population groups (PrEP-SUS) (BRASIL, 2017). Nonetheless, despite the progress seen in HIV prevention in recent years, the prevalence of HIV among MSM is still high (Saffier et al., 2017). As for PrEP, socio-structural and contextual barriers have been observed, such as access to health services, fear of disclosing sexual orientation, HIV-related stigma, and fear of being perceived as promiscuous (da Silva et al., 2021), as well as individual barriers, such as uncertainty about the efficacy of PrEP, concerns about side effects, low perceived risk of HIV (Magno et al., 2019), the incorporation of daily medication in the routine, and the impact on their social lives due to HIV stigma (Zucchi et al., 2021). Risk perception may be understood as a potential susceptibility assimilated by an individual of being affected by a danger, disease or injury, under certain behavioral conditions (Brewer et al., 2007). It is determined by multiple factors, including access to information, years of schooling, participation in HIV/AIDS NGO and HIV knowledge (Williams & Noyes, 2007). It is generally agreed that the likelihood of an individual changing his/her behavior and adopting protective attitudes is largely influenced by their state of mind in assessing a risk, danger, or severity of an outcome (Rogers, 1983). It’s important to consider that risk is not a neutral concept (Lupton, 1999), but has symbolic, cultural and moral dimensions which affect how people evaluate their behaviors and practices. In addition, values and meanings of risk also contribute to the way people position themselves in their practices and relationships. Studies have shown that high perceived risk of HIV among MSM is associated with the adoption of preventive measures like HIV testing (Khawcharoenporn et al., 2019; Stephenson et al., 2015), and PrEP use (Golub et al., 2013; Peng et al., 2018). Condom use is long known to be effective and associated with safer sex among MSM (Klein & Kaplan, 2012). Shaefer et al. (Schaefer et al., 2020) reported an association of high-risk perception of HIV and lack of condom use and also showed that an increase in condom use leads to a decrease in risk perception. However, a direct correlation between risk perception and real risk of HIV is highly complex (Plotzker et al., 2017), since other studies have shown that individuals at higher risk may perceive themselves at low or no risk of infection (Khawcharoenporn et al., 2019; MacKellar et al., 2007; Rutstein et al., 2020). HIV risk perception is considered an important predictor of HIV preventive measures. However, studies on the association of perceived risk of HIV and the acceptability of daily oral PrEP among MSM are still scarce in Latin America. In this paper, we aimed at investigating this association among MSM residing in 12 capital cities in Brazil.

Method

Study Design

This study reports findings from a cross-sectional biological and behavioral survey among MSM, conducted in 12 Brazilian capital cities in the five regions of Brazil, from June to December 2016: Manaus, Belém (North Region), Fortaleza, Recife, Salvador (Northeast Region), Brasília, Campo Grande (Central-West Region), Belo Horizonte, Rio de Janeiro, São Paulo (Southeast Region), Curitiba, and Porto Alegre (South Region). Participants were eligible for the study if they self-identified themselves as cisgender men; 18 years of age or older; had at least one sexual intercourse with another man or transgender woman in the past 12 months; reported spending most of their time in the selected city (i.e., living, studying, and/or working there); and received a valid study coupon. Each study participant was screened for eligibility prior to enrollment. The study was approved by the Research Ethics Committee of the Federal University of Ceará and registered with the National Ethics Research Committee (n. 1.024.053). As mentioned, written informed consent was asked and obtained from all participants, who could withdraw consent at any stage of the process or skip any questions perceived as too sensitive, too personal, or distressing.

Data Collection

Participants were recruited using respondent-driven sampling (RDS) as a sampling method aiming at obtaining a more robust and diverse sample (Gile & Handcock, 2010; Heckathorn, 1997). The formative phase of the study comprised group discussions with local MSM leaders, non-governmental organizations (NGO), potential participants, and local researchers. It aimed at identifying HIV risk-related behaviors, social and geographic organization of the MSM communities, potential limitations to recruitment, and decide on study operational issues, including the selection of seeds to start recruitment. As required by the RDS methods, 5 to 7 initial participants in each city—called seeds—were chosen purposively, following formative qualitative research. After participating in the interview and testing, each seed received three non-reproducible coupons to distribute to other MSM from their social networks. The interviewees recruited by the seeds were defined as the first wave of the study. This process was repeated until the a priori defined sample size was achieved in each site. Other methodological details may be found in Kendall et al. (Kendall et al., 2019).

Measures

The outcome variable in this analysis was acceptability of daily oral PrEP, as elicited in the question: “Are you willing to use PrEP?” (yes; no). It was explained to the participants that PrEP consisted of taking daily HIV-prevention drugs for those who were HIV negative to keep them free of the virus. MSM who self-reported HIV-positive at the time of the interview were excluded from the analysis because PrEP is recommended only for people who are HIV- negative. Also, at the time of data collection, PrEP was not yet available in Brazil. Therefore, the number of participants who had used PrEP before the study was too small (n = 46) for actually affecting the results, and they were not excluded from this analysis. The main exposure variable was perceived risk of HIV at the time of the interview (none; low; moderate; high). Because the proportions of acceptability among those with low or moderate risk perception were very similar, we decided to collapse these into one category due to power considerations for the multivariate analysis. Other covariates were selected from a literature review: i-sociodemographics: age (< 25 years; ≥ 25 years); race (black; non-black); schooling (<12 or 12+ years of formal education); stable partnership (yes; no); and socioeconomic class (A-B—higher; C-D-E—lower)—defined by the Brazilian Association of Research Organizations (Critério de Classificação Econônima Brasil., 2016) ; ii- sociobehavioral: condom use in receptive anal sex in the previous 6 months (always used; irregular use); any illicit drug use (cannabis, cocaine, crack, amphetamines, glue, solvents, ecstasy) within the last 6 months (yes; no); commercial sex in the last 6 months (yes; no); history of forced sexual intercourse (yes; no); at least one symptom of a STI—secretion, wart, ulcer, or lesion on penis or anus—in the previous 12 months (yes; no); previous HIV test in the lifetime (yes; no); history of discrimination due to sexual orientation in a lifetime (yes; no); number of sexual partners in the last 6 months (≤ 4; > 4 to ≤10; > 10); used online platforms to find partners in the last 6 months (yes; no); iii- HIV and prevention related variables: ever heard of PrEP (yes; no); self-reported participation in HIV/AIDS non-governmental organizations (NGOs) (yes; no); previous post-exposure prophylaxis (PEP) use (yes; no); and an indicator of HIV knowledge (low; medium; high). The knowledge score was based on 12 questions about HIV transmission and prevention, using item response theory, and dividing the answers into < 25%, 25% to 75%, and > 75% for low, medium, and high knowledge, respectively (Guimarães et al., 2019); iv- PrEP variables related to barriers to PrEP use and risk compensation (evaluated by stopping condom use while taking PrEP) were: would have trouble remembering to take PrEP daily (yes; no); is afraid of side effects (yes; no); is afraid of people thinking he is HIV-positive (yes; no); fear of getting other STI if using PrEP (yes; no); would not use PrEP if regular HIV testing was required (yes; no); would stop using condom if using PrEP (yes; no).

Data Analysis

The analysis was weighted due to the dependence between observations resulting from referral chains, and the probabilities of unequal selections due to the different sizes of each participant's network (Heckathorn, 1997). Each one of the 12 cities was defined as a stratum. In each stratum, the weighting was inversely proportional to the size of each participant's network, totaling the stratum size. The questions in the questionnaire that measured the network size of each MSM were: “How many men do you know and who also know you, who have sex with other men (oral or anal) in the last 12 months, live, study and/or work in [municipality], are 18 years old or older, you encountered or spoke with in the last two months?”. Overall proportions were weighted with Gile’s estimator in RDS Analyst software (Kendall et al., 2019). The analysis was conducted using the library for complex samples of STATA software version 15 (College Station, TX: StataCorp LLC). A descriptive analysis of the weighted frequency of acceptability of daily oral PrEP use, risk compensation, and potential barriers to PrEP use was conducted. In the analysis of the association between perceived risk of HIV and acceptability of PrEP, we fitted independent models yielding odds ratios adjusted for potential confounding factors, as well as their respective 95% confidence intervals (CIs). Variables with a p-value ≤ .10 in the bivariate analysis or considered epidemiologically relevant were chosen to start multivariate modeling. Percent change in the effect of unadjusted to adjusted OR was used to evaluate confounding (Rothman et al., 2008). Only variables with p < .05 remained in the final model.

Results

A total of 4,176 MSM were recruited in the study, and those who were known to be HIV-positive were excluded from this analysis (n = 303). In addition, those who did not answer the question “Are you willing to use PrEP? (n = 329)” were also excluded, leaving 3,544 MSM available for this analysis. The proportion of PrEP acceptability was 69.7%. When asked about their perceived risk of HIV, 23.5% declared none, 67.2% said it was low or moderate, and 9.3% said it was high. Most participants were black (66.1%), less than 25 years old (61.0%), had no stable partnership (86.9%), and they were of a lower socioeconomic class (57.0%). The PrEP acceptability was highest among those who also reported a high perceived risk of HIV (88.0%), followed by those who reported a low or moderate perceived risk (72.8%), and lowest among those who believed they had no risk of HIV (57.4%) (p = 0.001) (Table 1).
Table 1

Proportion of acceptability of daily oral PrEP according to sociodemographic and behavioral characteristics among MSM, Brazil, 2016 (N = 3544)

VariablesTotalPrEP acceptabilityORf (95% CI)
Na%bnc(%)dp -Valuee
Perceived risk of HIV infection
None70623.5471(57.4).0011.0
Low to moderate245367.21819(72.8)1.9 (1.3–3.1)
High2529.3213(88.0)5.5 (2.5–12.1)
Sociodemographic
Schooling
 < 12 years82231.9606(69.5).881
12 + years269068.01962(70.1)1.06 (0.71–1.58)
Age
 < 25 years223561.01675(73.5).011
 ≥ 25 years127738.9893(64.1)0.64 (0.45–0.92)
Race
Non-black125233.9906(66.6).281
Black227666.11672(70.8)1.22 (0.85–1.75)
Stable partnership
Yes44113.1322(70.2).901
No309586.92265(69.6)0.97 (0.60–1.56)
Socioeconomic class
Higher (A-B)166142.91234(71.5).381
Lower (C-D-E)188357.01358(68.2)0.86 (0.60–1.21)
Socio-behavioral
Condom use in receptive anal sex in the previous 6 months
Always used202263.01147(66.4).011
Irregular use150437.01436(74.7)1.49 (1.08–2.08)
Illicit drug use in previous 6 months
No169546.91229(67.2).201
Yes180353.01338(71.9)1.25 (0.88–1.77)
History of forced sexual intercourse
No278078.92016(67.9).061
Yes74221.1562(76.3)1.52 (0.98–2.36)
STI symptoms
Yes62817.7481(66.2).431
No290982.32106(70.4)0.83 (0.51–1.33)
Previous HIV test in the lifetime
No107235.2795(69.1).831
Yes247064.81795(69.9)1.04 (0.73–1.49)
History of discrimination due to sexual orientation in a lifetime.001
No103763.6744(63.1)1
Yes249465.41842(73.2)1.59 (1.12–2.27)
Number of sexual partners in previous 6 months
 ≤ 4199859.81426(68.2).661
 > 4 to ≤ 1083623.5629(71.4)1.16 (0.78–1.76)
 > 1071016.7537(72.3)1.21 (0.71–2.07)
Used online platforms to find partners
No113336.9815(63.1).011
Yes237363.01754(73.3)1.60 (1.11–2.31)
Self-reported participation in HIV/AIDS NGO
No317690.42335(71.2).011
Yes3479.6245(56.1)0.51 (0.29–0.89)
Commercial sex in previous 6 months
Yes55714.9405(61.2).071
No295585.12170(71.1)1.56 (0.96–2.54)
HIV prevention
Ever heard of PrEP
No260869.61908(68.7).441
Yes91730.4670(71.9)1.16 (0.79–1.72)
Previous PEP use
No336994.92458(68.9).0011
Yes1755.0134(83.7)2.3 (1.28–4.17)
HIV knowledge
Low79227.9563(72.9).571
Medium188346.91379(68.2)0.79 (0.52–1.23)
High86925.1650(68.8)0.82 (0.49–1.37)

aTotal in each category for each variable

bWeighted distribution of categories according to each variable, considering that missing data varies

cNumber of participants with PrEP acceptability in each category of each variable

dWeighted proportion of PrEP acceptability according to each category of each variable

ep-value comparing PrEP acceptability for each variable

fUnivariate Weighted Odds Ratio of PrEP acceptability with 95% confidence interval for each variable

Proportion of acceptability of daily oral PrEP according to sociodemographic and behavioral characteristics among MSM, Brazil, 2016 (N = 3544) aTotal in each category for each variable bWeighted distribution of categories according to each variable, considering that missing data varies cNumber of participants with PrEP acceptability in each category of each variable dWeighted proportion of PrEP acceptability according to each category of each variable ep-value comparing PrEP acceptability for each variable fUnivariate Weighted Odds Ratio of PrEP acceptability with 95% confidence interval for each variable The acceptability of daily oral PrEP use was higher among MSM under 25 years of age, who reported condomless anal intercourse, experienced discrimination due to their sexual orientation, who used online platforms to find partners, and who had previously used PEP (p < .05), and it was lower among who participate in HIV/AIDS NGOs (p < .05).The acceptability of PrEP was also higher among MSM who had experienced sexual violence (p = .06), although of borderline statistical significance at p-value level of .05 (Table 1). Regarding risk compensation, and potential barriers to PrEP use, 27.6% reported they would have trouble remembering to take PrEP every day, and 25.6% indicated they would not use PrEP if regular HIV testing was required. As for the fears associated with PrEP use, 61.6% reported fear of side effects, 34.2% feared they could be mistaken for having HIV, and 73.4% feared getting other STI upon using PrEP. Only 18.6% said they would stop using condoms if they were using PrEP. When analyzing this by the practice of condom use, it was observed that among those who used condoms irregularly 26.2% would not use condoms if on PrEP, while 14.5% would stop it among those who always used condoms in anal sex (Table 2).
Table 2

Prevalence of acceptability and knowledge of daily oral PrEP, risk compensation, and barriers to PrEP use among men who have sex with men. Brazil, 2016

VariableN%a
Acceptability of daily PrEP use259269.7
Trouble remembering to take PrEP daily100727.6
Would not use PrEP if regular testing was required83825.6
Afraid of side effects213761.6
Fear of people thinking they are HIV-positive109234.2
Fear of getting other STIs if using PrEP256373.4
Would stop using condom if use PrEP622b18.6
 Among those who always use condom in receptive anal sex28514.5
 Among those who used condoms irregularly in receptive anal sex33526.2

aWeighted using Gile’s estimator

b2 participants did not have receptive anal sex in the last 6 months

Prevalence of acceptability and knowledge of daily oral PrEP, risk compensation, and barriers to PrEP use among men who have sex with men. Brazil, 2016 aWeighted using Gile’s estimator b2 participants did not have receptive anal sex in the last 6 months In the multivariate analysis, a dose–response relationship was observed between acceptability of PrEP and self-reported risk: PrEP acceptability was two times higher (OR 1.88; 95% CI: 1.24–2.85) among MSM whose perceived risk of HIV infection was low or moderate, and six times higher (OR 5.68; 95% CI: 2.54–12.73) among MSM who self-reported high risk compared to MSM reporting no HIV risk (Table 3).
Table 3

Multivariate analysis of the association between perceived risk of HIV infection and acceptability of daily oral PrEP among men who have sex with men. Brazil, 2016

VariableAcceptability of PrEP(N = 3.345)b
ORa95%CIp-Values
Perceived risk of HIV infection
None1.00
Low to moderate1.881.24–2.85.00
High5.682.54–12.73.00
Race
Non-black1.00
Black1.441.00–2.07.05
Used online platforms to find partners
No1.00
Yes1.681.17–2.41.00
Commercial sex in previous 6 months
Yes1.00
No1.801.06–3.06.03
Previous PEP use
No1.00
Yes1.870.99–3.54.05

aWeighted by Gile’s estimator

bDue to missing variables, the final model had a reduction in the number of observations

Multivariate analysis of the association between perceived risk of HIV infection and acceptability of daily oral PrEP among men who have sex with men. Brazil, 2016 aWeighted by Gile’s estimator bDue to missing variables, the final model had a reduction in the number of observations

Discussion

PrEP is an effective preventive strategy for reducing the risk of HIV infection among MSM (BRASIL, 2017). In this study, a dose–response relationship was observed, whereby MSM with the highest risk perception of HIV reported higher rates of PrEP acceptability. Perceived risk of HIV infection varies across population groups and contexts (Cardona et al., 2012; Golub et al., 2013), while acceptability of a preventive technology is a complex, multidimensional phenomenon determined by the socioeconomic, political, and cultural context (Mensch et al., 2012). In low- and middle-income countries, in a context of limited use of PrEP and socioeconomic inequalities, specific factors tend to determine how acceptable PrEP is among MSM, such as level of schooling, knowledge of PrEP, and HIV risk perception (Yi et al., 2017). Individuals who believe they are at risk of acquiring a disease are more likely to adapt their behavior in order to reduce such a risk, while those who feel less at risk may be unlikely to adopt protective behaviors (MacKellar et al., 2007). It is important to stress that perceived and actual risk of acquiring HIV are not directly associated (MacKellar et al., 2007; Plotzker et al., 2017). A study conducted in northeastern Brazil found that transgender women who had condomless anal intercourse were almost seven times less likely to use PrEP (Soares et al., 2019) than the ones who always used a condom, indicating that involvement in contexts of increased vulnerability to HIV does not necessarily prompt increased interest in this prevention strategy. There is evidence that a significant proportion of people who seroconvert may perceive themselves to be at no or low risk of HIV (Corneli et al., 2014; MacKellar et al., 2005), which suggests that individuals who engage in sexual practices that involve a substantial risk of acquiring HIV may not perceive their context and/or sexual behavior as risky (MacKellar et al., 2005; Plotzker et al., 2017), leading to underestimation of real risk. For example, in this analysis, we observed that a lower proportion of participants who did not have commercial sex perceived themselves to be at a higher risk of HIV infection (7.87%), as compared to those who had commercial sex (17.84%) (p < .05) (Data not shown). However, those who did not have commercial sex were more willing to use PrEP, as indicated in Table 1. After adjustment for the perception of risk, this variable remains in the multivariate analysis (Table 3). Since the 1970s, the perceived risk of acquiring a disease has been shown to be an important motivator for diagnostic testing and an important component of health behaviors and interventions designed to protect or improve health (Kowalewski et al., 1997). Risk perception is therefore an important pre-condition for intention to use HIV prevention methods including PrEP (Chakrapani et al., 2021; Holloway et al., 2017). It is known that, when a protective health measure is relatively simple for the target public to adopt, the association between perceived risk and the measure tends to be stronger. However, the opposite also applies: When a measure is overly complex, the association tends to be weaker, because decisions about whether to adopt such a measure tend to be influenced by multiple factors (Brewer et al., 2007). In the case of PrEP, important issues have to be considered as it involves incorporating a routine—the daily ingestion of a pill; concerns with side effects and social impacts due to the stigma associated with HIV (Chan et al., 2016; Galea et al., 2011; Holloway et al., 2017; Meyers et al., 2014; Peng et al., 2018; Plotzker et al., 2017). Not withstanding the barriers and resistance to the daily use of PrEP, such as fear of getting other STIs when using PrEP, side effects, or being perceived as having HIV because of the use of antiretrovirals, a high proportion of the participants who felt they were at moderate or high risk of HIV infection reported they would accept daily PrEP. Furthermore, a small proportion (18.6%) declared they would not use a condom if they were using PrEP. However, we should note that the practice of anal sex without always using condoms was reported by a large proportion of MSM interviewed in our study (37%). In this group, 26.2% would not use condoms if on PrEP, as compared to 14.5% among those who always used condoms in anal sex in the past six months. This illustrates why HIV prevention programs should guide users about the available methods and their specificities, even when using PrEP. Programs should encourage MSM to make conscious decisions about their sexual health and affinities (Terto, 2015). While risk perceptions are dynamic and mutable as sexual behaviors and context change (Rutstein et al., 2020), the main driver behind people’s decision to not take PrEP in our study appears to be a low self-perception of HIV. (Whitfield et al., 2018). Given the availability of oral PrEP in the public health care system in Brazil, we suggest emphasizing counseling about self-perception of HIV risk as part of routine HIV prevention services (Mansergh et al., 2012).

Limitations

The limitations of studies involving RDS have been described widely in the literature (Gile & Handcock, 2010). As the sampling was non-random and depended on chain-referrals via contact networks, the results of this article cannot be generalized to the MSM in the 12 cities studied. It is important to note that, as found in other studies investigating PrEP acceptability, a stated intention to use does not necessarily translate into actual use. The participants may misclassify their answers to the questions of PrEP acceptability because it is hard for people to accurately know exactly what they would do in hypothetical situations. The data were self-reported, which could mean under- or over- reporting the acceptability of daily PrEP, especially because these questions were asked when PrEP was not yet available in the public health service and the previous knowledge about PrEP was limited among the participants. In order to reduce such bias, a brief explanation of PrEP was given before the questions about it were asked. Furthermore, during the study, questions were asked about sexual experiences and behaviors that are subject to social desirability bias, which could be a weakness given that the data were gathered in face-to-face interviews. To counteract this bias, interviews were conducted in an MSM-friendly environment and fieldworkers were trained to remain neutral and supportive throughout the interview.

Conclusion

In this study, risk perception was found to be associated with the acceptability of daily PrEP. This suggests that the development of HIV prevention measures designed to increase risk perception among MSM who are vulnerable to HIV should be considered, whether through communication campaigns about the PrEP services on offer at the public health service or through health education initiatives run by health workers or NGOs. In addition, it is necessary to promote strategies of communication that do not increase PrEP stigma or HIV anxiety, but rather focus on the positive aspects associated with its use, including sexual autonomy and health empowerment, among others. At a time when global concern for HIV has been somewhat diminished by both effective treatments and the current COVID-19 pandemic, the need for HIV guidance designed to help MSM re-assess their own risk is important, especially for those who may underestimate or deny such risks, in order to enable the identification of MSM who could benefit from incorporating PrEP into their daily routine. This implies tackling the challenge of helping individuals at higher risk of infection to gain awareness of their status and ensuring the availability of PrEP as a viable, effective option at their disposal.
  42 in total

1.  Different preventions methods lead to different choices? Questions on HIV/AIDS prevention for men who have sex with men and other vulnerable populations.

Authors:  Veriano Terto
Journal:  Rev Bras Epidemiol       Date:  2015-09

Review 2.  Rethinking perceived risk and health behavior: a critical review of HIV prevention research.

Authors:  M R Kowalewski; K D Henson; D Longshore
Journal:  Health Educ Behav       Date:  1997-06

3.  Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.

Authors:  Beatriz Grinsztejn; Brenda Hoagland; Ronaldo I Moreira; Esper G Kallas; Jose V Madruga; Silvia Goulart; Iuri C Leite; Lucilene Freitas; Luana M S Martins; Thiago S Torres; Ricardo Vasconcelos; Raquel B De Boni; Peter L Anderson; Albert Liu; Paula M Luz; Valdiléa G Veloso
Journal:  Lancet HIV       Date:  2018-02-18       Impact factor: 12.767

4.  A Global Estimate of the Acceptability of Pre-exposure Prophylaxis for HIV Among Men Who have Sex with Men: A Systematic Review and Meta-analysis.

Authors:  Peng Peng; Shu Su; Christopher K Fairley; Minjie Chu; Shengyang Jiang; Xun Zhuang; Lei Zhang
Journal:  AIDS Behav       Date:  2018-04

Review 5.  Acceptability in microbicide and PrEP trials: current status and a reconceptualization.

Authors:  Barbara S Mensch; Ariane van der Straten; Lauren L Katzen
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

6.  Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.

Authors:  Albert Y Liu; Stephanie E Cohen; Eric Vittinghoff; Peter L Anderson; Susanne Doblecki-Lewis; Oliver Bacon; Wairimu Chege; Brian S Postle; Tim Matheson; K Rivet Amico; Teri Liegler; M Keith Rawlings; Nikole Trainor; Robert Wilder Blue; Yannine Estrada; Megan E Coleman; Gabriel Cardenas; Daniel J Feaster; Robert Grant; Susan S Philip; Richard Elion; Susan Buchbinder; Michael A Kolber
Journal:  JAMA Intern Med       Date:  2016-01       Impact factor: 21.873

7.  Factors Associated with PrEP Refusal Among Transgender Women in Northeastern Brazil.

Authors:  Fabiane Soares; Sarah MacCarthy; Laio Magno; Luís Augusto Vasconcelos da Silva; Leila Amorim; Amy Nunn; Catherine E Oldenburg; Inês Dourado
Journal:  AIDS Behav       Date:  2019-10

8.  High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy.

Authors:  Kathrine Meyers; Kristina Rodriguez; Robert W Moeller; Ilana Gratch; Martin Markowitz; Perry N Halkitis
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

Review 9.  Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis.

Authors:  Siyan Yi; Sovannary Tuot; Grace W Mwai; Chanrith Ngin; Kolab Chhim; Khoundyla Pal; Ewemade Igbinedion; Paula Holland; Sok Chamreun Choub; Gitau Mburu
Journal:  J Int AIDS Soc       Date:  2017-06-26       Impact factor: 5.396

10.  A scoping review of prevalence, incidence and risk factors for HIV infection amongst young people in Brazil.

Authors:  Igor Pedrosa Saffier; Hélia Kawa; Guy Harling
Journal:  BMC Infect Dis       Date:  2017-10-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.